Is cyclosporine A transport inhibited by pravastatin via multidrug resistant protein 2?

European Journal of Clinical Pharmacology

Volumn 66, Issue 2, 2010, Pages 153-158

  Kato, Ryuji ^a   Nishide, Mami ^a   Kozu, Chihiro ^a   Iwamoto, Asuka ^a   Urashima, Kazuya ^b   Suzuki, Kaoru ^b   Ijiri, Yoshio ^a   Hayashi, Tetsuya ^a,b   Tanaka, Kazuhiko ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA MEDICAL COLLEGE HOSPITAL   (Japan)

Author keywords

Calcein; Cyclosporine A; MRP2; Pravastatin

Indexed keywords

CALCEIN; CYCLOSPORIN A; GLYCOPROTEIN P; PRAVASTATIN; PROBENECID;

ADULT; APICAL MEMBRANE; ARTICLE; BASOLATERAL MEMBRANE; CASE REPORT; CELL STRAIN CACO 2; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TISSUE CULTURE;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL SURVIVAL; CYCLOSPORINE; DRUG INTERACTIONS; FEMALE; FLUORESCEINS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMYOSITIS; PRAVASTATIN;

EID: 76949106654     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-009-0740-6     Document Type: Article

References (18)

1. YY Chiu K Higaki BL Neudeck JL Barnett LS Welage GL Amidon 2003 Human jejunal permeability of cyclosporin A: influence of surfactants on P-glycoprotein efflux in Caco-2 cells Pharm Res 20 749 756 10.1023/A: 1023481418576 1:CAS:528:DC%2BD3sXjtFKgs7c%3D 12751630 (Pubitemid 36515307)
2. T Sakaeda K Takara M Kakumoto N Ohmoto T Nakamura K Iwaki Y Tanigawara K Okumura 2002 Simvastatin and lovastatin, but not pravastatin, interact with MDR1 J Pharm Pharmacol 54 419 423 10.1211/0022357021778493 1:CAS:528: DC%2BD38XisVKhsr4%3D 11902809 (Pubitemid 34232343)
3. E Yamamoto T Yamashita T Tanaka K Kataoka Y Tokutomi ZF Lai YF Dong S Matsuba H Ogawa S Kim-Mitsuyama 2007 Pravastatin enhances beneficial effects of olmesartan on vascular injury of salt-sensitive hypertensive rats, via pleiotropic effects Arterioscler Thromb Vasc Biol 27 556 563 10.1161/01.ATV.0000254855.24394.f9 1:CAS:528:DC%2BD2sXhsVSitrc%3D 17170375 (Pubitemid 46263400)
4. T Yamagata K Kinoshita Y Nozaki M Sugiyama S Ikoma M Funauchi 2007 Effects of pravastatin in murine collagen-induced arthritis Rheumatol Int 27 631 639 10.1007/s00296-006-0270-9 1:CAS:528:DC%2BD2sXktlSmsL4%3D 17119970 (Pubitemid 46625346)
5. D Kobayashi T Nozawa K Iwaki J Nezu A Tsuji I Tamai 2003 Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane J Pharmacol Exp Ther 306 703 708 10.1124/jpet.103.051300 1:CAS:528:DC%2BD3sXlslGlu70%3D 12724351 (Pubitemid 36886171)
6. Y Shitara T Itoh H Sato LI AP Y Sugiyama 2003 Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A J Pharmacol Exp Ther 304 610 616 10.1124/jpet.102.041921 1:CAS:528:DC%2BD3sXpvVCguw%3D%3D 12538813 (Pubitemid 36152336)
7. W Jacobsen G Kirchner K Hallensleben L Mancinelli M Deters I Hackbarth LZ Benet KF Sewing U Christians 1999 Comparison of cytochrome P-450-dependent metabolism and drug interactions of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors lovastatin and pravastatin in the liver Drug Metab Dispos 27 173 179 1:CAS:528:DyaK1MXhslanu7o%3D 9929499
8. CW Holtzman BS Wiggins SA Spinler 2006 Role of P-glycoprotein in statin drug interactions Pharmacotherapy 26 1601 1607 10.1592/phco.26.11.1601 1:CAS:528:DC%2BD28Xht1ymsrrN 17064205 (Pubitemid 44704473)
9. LS Gan MA Moseley B Khosla PF Augustijns TP Bradshaw RW Hendren DR Thakker 1996 CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells Drug Metab Dispos 24 344 349 1:CAS:528:DyaK28Xhs1Gjurw%3D 8820426
10. M Jin T Shimada K Yokogawa M Nomura J Ishizaki Y Piao Y Kato A Tsuji K Miyamoto 2006 Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice Biochem Pharmacol 72 1042 1050 10.1016/j.bcp.2006.07.020 1:CAS:528: DC%2BD28Xps1Wlsrc%3D 16939683 (Pubitemid 44374466)
11. S Matsushima K Maeda C Kondo M Hirano M Sasaki H Suzuki Y Sugiyama 2005 Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein J Pharmacol Exp Ther 314 1059 1067 10.1124/jpet.105.085589 1:CAS:528:DC%2BD2MXpvFSqsrk%3D 15901800 (Pubitemid 41205969)
12. M Akashi A Tanaka H Takikaw 2006 Effect of cyclosporin A on the biliary excretion of cholephilic compounds in rats Hepatol Res 34 193 198 10.1016/j.hepres.2005.08.013 1:CAS:528:DC%2BD28XitVKnsb8%3D 16476567 (Pubitemid 43316516)
13. J Taipalensuu H Tornblom G Lindberg C Einarsson F Sjoqvist H Melhus P Garberg B Sjostrom B Lundgren P Artursson 2001 Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers J Pharmacol Exp Ther 299 164 170 1:CAS:528:DC%2BD3MXntFWlt7Y%3D 11561076
14. A Seithel J Karlsson C Hilgendorf A Bjorquist AL Ungell 2006 Variability in mRNA expression of ABC- and SLC-transporters in human intestinal cells: comparison between human segments and Caco-2 cells Eur J Pharm Sci 28 291 299 10.1016/j.ejps.2006.03.003 1:CAS:528:DC%2BD28XltF2kurk%3D 16704924 (Pubitemid 44218740)
15. T Fujita H Yamada M Fukuzumi A Nishimaki A Yamamoto S Muranishi 1997 Calcein is excreted from the intestinal mucosal cell membrane by the active transport system Life Sci 60 307 313 10.1016/S0024-3205(96)00631-5 1:CAS:528:DyaK2sXhvF2ntQ%3D%3D 9010486 (Pubitemid 27037318)
16. HM Prime-Chapman RA Fearn AE Cooper V Moore BH Hirst 2004 Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells J Pharmacol Exp Ther 311 476 484 10.1124/jpet.104.068775 1:CAS:528:DC%2BD2cXptVKrtL8%3D 15210835 (Pubitemid 39391531)
17. T Koga K Fukuda Y Shimada M Fukami H Koike Y Tsujita 1992 Tissue selectivity of pravastatin sodium, lovastatin and simvastatin. The relationship between inhibition of de novo sterol synthesis and active drug concentrations in the liver, spleen and testis in rat Eur J Biochem 209 315 319 10.1111/j.1432-1033.1992.tb17291.x 1:CAS:528:DyaK38Xls1eltLY%3D 1396707
18. M Horikawa Y Kato CA Tyson Y Sugiyama 2002 The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites Drug Metabol Pharmacokin 17 23 33 10.2133/dmpk.17.23 1:CAS:528:DC%2BD38XksVGrsbg%3D